laitimes

Jiu'an Medical's single-quarter revenue was 760 million: down 49% year-on-year, and the net profit after deducting non-profits was 316 million

author:Thunder delivery
Jiu'an Medical's single-quarter revenue was 760 million: down 49% year-on-year, and the net profit after deducting non-profits was 316 million

Lei Jianping on April 28

Tianjin Jiu'an Medical Electronics Co., Ltd. (stock code: 002432, stock abbreviation: Jiu'an Medical) released its financial report today. According to the financial report, Jiu'an Medical's revenue in the first quarter of 2024 was 762 million, down 49% from 1.495 billion yuan in the same period last year.

Jiu'an Medical's single-quarter revenue was 760 million: down 49% year-on-year, and the net profit after deducting non-profits was 316 million

Jiu'an Medical's net profit in the first quarter of 2024 was 247 million yuan, down 58.86% from 600 million yuan in the same period last year, and the net profit after deducting non-profits was 316 million yuan, down 10.58% from 353 million yuan in the same period last year.

As of March 31, 2024, Liu Yi held 23.84% of the shares through Shihezi Sanhe Equity Investment Partnership (Limited Partnership), Bank of China Co., Ltd. - Huabao CSI Healthcare Exchange-traded Open-ended Index Securities Investment Fund held 2.22% of the shares, and Tianjin Jiu'an Medical Electronics Co., Ltd. held 2.05% of the shares in the 2022 Employee Stock Ownership Plan.

Jiu'an Medical's single-quarter revenue was 760 million: down 49% year-on-year, and the net profit after deducting non-profits was 316 million

As of March 31, 2024, Jiu'an Medical's shareholding structure

Hong Kong Securities Clearing Co., Ltd. holds 1.53% of the shares, Agricultural Bank of China Co., Ltd. - CSI 500 ETF holds 0.88%, Zhou Qun holds 0.65%, China Construction Bank Corporation - ICBC Credit Suisse Frontier Medical Equity Securities Investment Fund holds 0.65%, Chen Decai holds 0.43%, Zhao Zhihai holds 0.4%, and Feng Junju holds 0.35%.

As of December 31, 2023, Liu Yi held 23.87% of the shares through Shihezi Sanhe Equity Investment Partnership (Limited Partnership), Tianjin Jiu'an Medical Electronics Co., Ltd. - 2022 Employee Stock Ownership Plan held 2.44%, and Bank of China Co., Ltd. - Huabao CSI Medical Exchange-traded Open-ended Index Securities Investment Fund held 2.29%;

Jiu'an Medical's single-quarter revenue was 760 million: down 49% year-on-year, and the net profit after deducting non-profits was 316 million

As of December 31, 2023, Jiu'an Medical's shareholding structure

Zhou Qun holds 0.66%, Feng Junju holds 0.65%, Hong Kong Securities Clearing Co., Ltd. holds 0.56%, Yu Ronghu holds 0.52%, China Merchants Bank Co., Ltd. - GF Value Core Mixed Securities Investment Fund holds 0.49%, Chen Decai holds 0.43%, and Agricultural Bank of China Co., Ltd. - CSI 500 ETF holds 0.4%.

The comparison can find that the equity of Jiu'an Medical is quite dispersed, however, the overall change in the first quarter of 2024 is not much.

———————————————

Lei Di was founded by Lei Jianping, a media person, if it is reprinted, please indicate the source.

Read on